Cocrystallization-Driven Double-Optimized Stratagem toward Directional Self-Assembly for the First Ternary Salt Cocrystal of Cardiotonic Drug Milrinone with Different Phenolic Acids Exhibits Optimal <i>In Vitro</i>/<i>Vivo</i> Biopharmaceutical Peculiarities

Su-Su Meng,Yue-Ming Yu,Fan-Zhi Bu,Cui-Wei Yan,Zhi-Yong Wu,Yan-Tuan Li
DOI: https://doi.org/10.1021/acs.molpharmaceut.3c00230
2023-01-01
Molecular Pharmaceutics
Abstract:The current research leverages the structural featuresand propertysuperiorities along with benefits in protecting cardiovascular systemof gallic acid (GLC) and gentisic acid (HGA) to optimize invitro/vivo peculiarities of cardiotonicdrug milrinone (MIL) through developing a stratagem of cocrystallization-drivendouble-optimized ternary salt cocrystal. This strategy assembles MILternary salt cocrystal by shaping a cocrystallization moiety relyingon noncovalent interplays with GLC to obtain permeability advancementand molding a salt segment via the salification of proton transferbetween HGA and MIL molecules to facilitate solubility enhancement.While the ameliorative in vitro properties furthermodulate the in vivo pharmacokinetic behaviors, thusfulfilling a dual optimization of MIL's biopharmaceutical characteristicson both in vitro and in vivo aspects.Along this line, the first MIL ternary salt cocrystal, viz., [HMIL+-GA(-)]-MIL-GLC-H2O (denoted asMTSC hereinafter), has been satisfactorily constructed and preciselystructurally identified by diversified techniques. The single-crystalX-ray diffraction experiment validates that a molecular salt [HMIL+-GA(-)] species cocrystallizes with one neutralMIL, two GLC, and five solvent water molecules, among which the organicconstituents compose laminated hydrogen bond networks, and then areself-assembled by water molecules to a 3D supramolecular structure.The unique structural feature and stacking pattern of MTSC make boththe permeability and solubility be respectively enhanced by 9.69 timesand 5.17- to 6.03-fold compared with the parent drug per se. The experimental outcomes are powerfully supported by associatedcalculations based on density functional theory. Intriguingly, theseoptimal in vitro physicochemical natures of MTSChave been potently converted into strengths of in vivo pharmacokinetics, showcasing the elevated drug plasma concentration,elongated half-life, alongside advanced bioavailability. Consequently,this presentation not just contributes a brand-new crystalline formwith utility values, but ushers in a new dimension of ternary saltcocrystals for improving in vitro/vivo limitations of poor drug bioavailability.
What problem does this paper attempt to address?